Molecular and Cellular Biochemistry

, Volume 341, Issue 1, pp 33–41

Trends in advanced glycation end products research in diabetes mellitus and its complications

  • José D. Méndez
  • Jianling Xie
  • Montserrat Aguilar-Hernández
  • Verna Méndez-Valenzuela
Article

DOI: 10.1007/s11010-010-0434-5

Cite this article as:
Méndez, J.D., Xie, J., Aguilar-Hernández, M. et al. Mol Cell Biochem (2010) 341: 33. doi:10.1007/s11010-010-0434-5

Abstract

Advanced glycation end-products (AGEs) are heterogeneous groups of compounds that result from the non-enzymatic reaction of reducing sugars with free amino groups of biological molecules such as proteins, lipids, and nucleic acids. A large number of studies have been focused on AGEs metabolism, analysis, treatments, and their implications in the pathogenesis of diseases, especially in diabetes mellitus. Here, we review recent advances in the understanding of pathological complications caused by the production of AGEs. We provide an overview of the most important issues published within this area in last years; we also present the number of scientific papers related to AGEs available since 1950 until 2008 in the most important fields including metabolism, physiology, and pharmacology, thus as analytical methods for AGE detection and quantification and studies carried out in human body fluids. Data were collected from ovidSP.

Keywords

Advanced glycation end products Hyperglycemia Diabetes mellitus Diabetic complications 

Copyright information

© Springer Science+Business Media, LLC. 2010

Authors and Affiliations

  • José D. Méndez
    • 1
    • 2
  • Jianling Xie
    • 3
  • Montserrat Aguilar-Hernández
    • 4
  • Verna Méndez-Valenzuela
    • 5
  1. 1.Medical Research Unit in Metabolic Diseases, National Medical Center Mexican Institute of Social SecurityMexicoMexico
  2. 2.School of OdontologyNational Autonomous University of México (UNAM)Mexico CityMexico
  3. 3.Department of Cell Physiology and Pharmacology, Faculty of Medicine and BiosciencesUniversity of LeicesterLeicesterUK
  4. 4.Department of Biochemistry, Faculty of Medicine and BiosciencesUniversity of LeicesterLeicesterUK
  5. 5.Division of DiabetesUniversity of Texas Health Science Center at San Antonio, (UTHSCSA)San AntonioUSA

Personalised recommendations